HCRS logo
 

Members of the society


The Society has the following categories of member: regular members, honorary, probationary, and inactive members.

Regular members of the Society are selected from among distinguished scientists whose research field is focused on the cardiovascular system. Potential members are reviewed by the Society's membership Evaluation Committee and the Committee's suggestions are submitted to the Board, which has the final responsibility for selecting candidates for membership.

Members may be of Greek or other nationality, not only cardiologists, but scientists with a high level of scientific education, focus, and devotion to their research.

Each membership candidate should submit an application to the Evaluation Committee, including a detailed curriculum vitae detailing the applicant's research work, publications, scholarships, and research experience.

Regular members of the Society will be reviewed every three years by the Evaluation Committee, in order to ensure that their research activity is sufficient to justify their continuing membership status. Otherwise, at the discretion of the Board they may be reclassified as inactive members.

Probationary members of the Society are scientists with research interest in the cardiovascular system, who are under thirty years old, and who, while not satisfying the criteria for regular membership, show great promise in their field.

Honorary members are nominated by decision of the Board, as a means of recognising scientists who have an exceptional body of past research work in the cardiovascular field, but who are no longer particularly active.


Those interested in applying for membership should contact the membership secretary at the e-mail address given on the "Contact" page.


 

Go to top Top of page




CRF_button

CRF_button

Hot Articles


  1. Williams B, Cockcroft JR, Kario K et al. Effects of Sacubitril/Valsartan Versus Olmesartan on Central Hemodynamics in the Elderly With Systolic Hypertension: The PARAMETER Study
    Hypertension. 2017;69:411-420. … more More
  2. Aro AL, Rusinaru C, Uy-Evanado A et al. Syncope and risk of sudden cardiac arrest in coronary artery disease. Int. J. Cardiol. 2017; 231:26-30 … more More
  3. Raaijmakers A, Zhang ZY, Claessens J et al. Does Extremely Low Birth Weight Predispose to Low-Renin Hypertension? Hypertension. 2017; 69:443-449. … more More
  4. McCord J, Cabrera R, Lindahl B et al for the TRAPID-AMI Investigators. Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department.
    Circ Cardiovasc Qual Outcomes. 2017;10:e003101. … more More
  5. Aisu H, Saito M, Inaba S et al. Association of worsening arterial stiffness with incident heart failure in asymptomatic patients with cardiovascular risk factors. Hypertens Res 2017 40: 173-180 … more More
  6. Galløe AM, Kelbæk H, Thuesen L et al. 10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents. JACC 2017;69:616-624 … more More
  7. Nielles-Vallespin, S., Khalique, Z., et al. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance JACC 2017;69:661-676 … more More
  8. Yeh, R. W., Silber, S., et al. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program . JACC:Cardiov. Interv. 2017;10:247-254 … more More
  9. Rezkalla, S. H., Stankowski, R. V., et al. Management of No-Reflow Phenomenon in the Catheterization Laboratory. JACC:Cardiov. Interv. 2017;10:215-223 … more More
  10. Mahabadi, A. A., Möhlenkamp, S., et al. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    JACC: Cardiov. Imag. 2017;10:143-153 … more More

Sign up for our newsletter:

Name:

Email: